{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:27:07Z","timestamp":1773973627171,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ygyno.2023.03.021","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T13:35:12Z","timestamp":1680788112000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ovarian preservation compared to oophorectomy in premenopausal women with early-stage, low-grade endometrial Cancer: A cost-effectiveness analysis"],"prefix":"10.1016","volume":"173","author":[{"given":"Miriam L.","family":"Hernandez-Zepeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth G.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Bruegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2023.03.021_bb0010","author":"Uterine Cancer"},{"issue":"16","key":"10.1016\/j.ygyno.2023.03.021_bb0015","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2217\/fon.14.192","article-title":"USA endometrial Cancer projections to 2030: should we be concerned?","volume":"10","author":"Sheikh","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.ygyno.2023.03.021_bb0020","author":"Morice"},{"key":"10.1016\/j.ygyno.2023.03.021_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.12.1213","article-title":"Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema","author":"Matsuo","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.03.021_bb0030","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.2008.19.8150","article-title":"Safety of ovarian preservation in premenopausal women with endometrial cancer","volume":"27","author":"Wright","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.03.021_bb0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AOG.0000000000001181","article-title":"Utilization and outcomes of ovarian conservation in premenopausal women with endometrial cancer","volume":"127","author":"Wright","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ygyno.2013.08.024","article-title":"Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean gynecologic oncology group study","volume":"131","author":"Lee","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.06.041","article-title":"Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean gynecologic oncology group","volume":"115","author":"Lee","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.021_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2017.09.027","article-title":"Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer","volume":"147","author":"Matsuo","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.021_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2015.07.012","article-title":"Ovarian involvement in endometrioid adenocarcinoma of uterus","volume":"138","author":"Lin","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/AOG.0000000000001647","article-title":"Ovarian conservation and overall survival in young women with early-stage low-grade endometrial Cancer","volume":"128","author":"Matsuo","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study","volume":"24","author":"Barakat","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses\u2019 health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2019.08.007","article-title":"Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer","volume":"155","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"35","key":"10.1016\/j.ygyno.2023.03.021_bb0090","doi-asserted-by":"crossref","first-page":"59940","DOI":"10.18632\/oncotarget.18404","article-title":"Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer","volume":"8","author":"Jia","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000002142","article-title":"Risk of subsequent ovarian Cancer after ovarian conservation in young women with stage I Endometrioid endometrial Cancer","volume":"130","author":"Matsuo","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.021_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.021_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.021_bb0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2020.08.017","article-title":"A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1\/G2 endometrioid endometrial cancer","volume":"159","author":"Shen","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1447-0756.2010.01354.x","article-title":"Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage i endometrial carcinoma","volume":"37","author":"Pan","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0130","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00404-019-05288-5","article-title":"The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas","volume":"300","author":"Zhan","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0135","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.021_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.ygyno.2023.03.021_bb0145","doi-asserted-by":"crossref","first-page":"900.e1","DOI":"10.1016\/j.ajog.2020.06.040","article-title":"Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications","volume":"223","author":"Chow","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/AOG.0000000000002142","article-title":"Risk of subsequent ovarian cancer after ovarian preservation in young women with stage I endometrial cancer","volume":"130","author":"Matsuo","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"22","key":"10.1016\/j.ygyno.2023.03.021_bb0155","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.ygyno.2023.03.021_bb0160","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.021_bb0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/AOG.0000000000003171","article-title":"U.S. Food and Drug Administration-approved poly (ADP-ribose) polymerase inhibitor maintenance therapy for recurrent ovarian Cancer: a cost-effectiveness analysis","volume":"133","author":"Dottino","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ygyno.2005.01.028","article-title":"Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis","volume":"97","author":"Rocconi","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0175","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2007.04.015","article-title":"Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer","volume":"106","author":"Rankins","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.021_bb0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2217\/WHE.09.49","article-title":"Costs of hormonal and nonhormonal prescription medications for hot flashes","volume":"5","author":"Williams-Frame","year":"2009","journal-title":"Women Health"},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.021_bb0185","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.021_bb0190","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2018.04.558","article-title":"Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer","volume":"149","author":"Ferguson","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.03.021_bb0195","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","article-title":"Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis","volume":"20","author":"Grann","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.021_bb0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.esxm.2019.01.005","article-title":"Impact of vulvovaginal atrophy of menopause in Spanish women: prevalence and symptoms according to the EVES study","volume":"7","author":"Palacios","year":"2019","journal-title":"Sex Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:39Z","timestamp":1758773019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"alternative-id":["S0090825823001683"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian preservation compared to oophorectomy in premenopausal women with early-stage, low-grade endometrial Cancer: A cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}